Tobias Ostler is Head of Biologics at Dr. Regenold GmbH, an international operating service provider for Development, Regulatory and Market Access. Before joining the organisation Tobias held different industry positions in the field of biologics early stage development in Switzerland, Germany and Sweden.
Tobias received his degree in pharmaceutical chemistry at University of Tübingen, Germany and his degree in biology at University of Freiburg, Germany. Tobias holds a PhD in immunology of the Max-Planck-Institute of Immunobiology Freiburg, Germany.
